Tyrosine kinase inhibitors

Details for Australian Patent Application No. 2006306496 (hide)

Owner Merck & Co., Inc.

Inventors Lim, Jongwon; Ortega Gabarda, Ana Esther

Agent Spruson & Ferguson

Pub. Number AU-A-2006306496

PCT Pub. Number WO2007/050380

Priority 60/728,997 21.10.05 US

Filing date 18 October 2006

Wipo publication date 3 May 2007

International Classifications

A01N 43/00 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds

C07D 223/00 (2006.01) Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom

C07D 321/00 (2006.01) Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups

C07D 331/02 (2006.01) Heterocyclic compounds having sulfur, selenium, or tellurium atoms as the only ring hetero atoms

Event Publications

1 May 2008 PCT application entered the National Phase

  PCT publication WO2007/050380 Priority application(s): WO2007/050380

28 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

4 November 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006306497-3-piperidin-4-yl-indole ORL-1 receptor modulators

2006306491-Piperazine derivatives useful as CCR5 antagonists